Design and analysis of longitudinal trials of antimicrobial use at the end of life: to give or not to give?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design and analysis of longitudinal trials of antimicrobial use at the end of life: to give or not to give?

Published:2019-01 Issue: Volume:10 Page:204209861882021
ISSN:2042-0986
Container-title:Therapeutic Advances in Drug Safety
language:en
Short-container-title:Therapeutic Advances in Drug Safety

Author:

Juthani-Mehta Manisha¹²,Allore Heather G.³¹⁴^ORCID

Affiliation:

1. Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA

2. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

3. Yale University School of Medicine, 300 George St, Suite 775, New Haven, CT 06511, USA

4. Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA

Funder

National Institute on Aging

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1177/2042098618820210

Reference61 articles.

1. Inappropriate medication use and polypharmacy in end-stage cancer patients: Isn't it the family doctor's role to de-prescribe much earlier?

2. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

3. Treatment of the Dying in the Acute Care Hospital

4. Antimicrobial Use at the End of Life Among Hospitalized Patients With Advanced Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Subcutaneous Administration of Antibiotics to Control Infections in Elder Palliative Patients: A Systematic Review;American Journal of Hospice and Palliative Medicine®;2023-03-25

2. Association of entry into hospice or palliative care consultation during acute care hospitalization with subsequent antibiotic utilization;Clinical Microbiology and Infection;2023-01

3. Antibiotic Treatment in End Stage Cancer Patients; Advantages and Disadvantages;Cancer Informatics;2023-01

4. Factors That Influence the Prescription of Antibiotic Therapy at the End-of-Life: Construction and Validation of a Scale;Cureus;2022-11-20

5. End-of-Life Antibiotherapy: Factors Associated With Prescription;Cureus;2022-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3